169 related articles for article (PubMed ID: 24947312)
21. Tumor-treating fields plus chemotherapy versus chemotherapy alone for glioblastoma at first recurrence: a post hoc analysis of the EF-14 trial.
Kesari S; Ram Z;
CNS Oncol; 2017 Jul; 6(3):185-193. PubMed ID: 28399638
[TBL] [Abstract][Full Text] [Related]
22. Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme.
Hunn MK; Bauer E; Wood CE; Gasser O; Dzhelali M; Ancelet LR; Mester B; Sharples KJ; Findlay MP; Hamilton DA; Hermans IF
J Neurooncol; 2015 Jan; 121(2):319-29. PubMed ID: 25366363
[TBL] [Abstract][Full Text] [Related]
23. Gamma Knife Stereotactic Radiosurgery in Combination with Bevacizumab for Recurrent Glioblastoma.
Morris SL; Zhu P; Rao M; Martir M; Zhu JJ; Hsu S; Ballester LY; Day AL; Tandon N; Kim DH; Shepard S; Blanco A; Esquenazi Y
World Neurosurg; 2019 Jul; 127():e523-e533. PubMed ID: 30954746
[TBL] [Abstract][Full Text] [Related]
24. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
[TBL] [Abstract][Full Text] [Related]
25. Primary gliosarcoma--clinical experience from a regional cancer centre in north India.
Biswas A; Kumar N; Kumar P; Vasishta RK; Gupta K; Sharma SC; Patel F; Mathuriya SN
Br J Neurosurg; 2011 Dec; 25(6):723-9. PubMed ID: 21591852
[TBL] [Abstract][Full Text] [Related]
26. Nivolumab for patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series.
Chamberlain MC; Kim BT
J Neurooncol; 2017 Jul; 133(3):561-569. PubMed ID: 28500559
[TBL] [Abstract][Full Text] [Related]
27. CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience.
Chatzikonstantinou G; Zamboglou N; Archavlis E; Strouthos I; Zoga E; Milickovic N; Hilaris B; Baltas D; Rödel C; Tselis N
Strahlenther Onkol; 2018 Dec; 194(12):1171-1179. PubMed ID: 30203110
[TBL] [Abstract][Full Text] [Related]
28. Intra-arterial carboplatin as a salvage strategy in the treatment of recurrent glioblastoma multiforme.
Fortin D; Morin PA; Belzile F; Mathieu D; Paré FM
J Neurooncol; 2014 Sep; 119(2):397-403. PubMed ID: 24947313
[TBL] [Abstract][Full Text] [Related]
29. Trans sodium crocetinate with temozolomide and radiation therapy for glioblastoma multiforme.
Gainer JL; Sheehan JP; Larner JM; Jones DR
J Neurosurg; 2017 Feb; 126(2):460-466. PubMed ID: 27177177
[TBL] [Abstract][Full Text] [Related]
30. Reirradiation for recurrent head and neck cancer with salvage interstitial pulsed-dose-rate brachytherapy: Long-term results.
Strnad V; Lotter M; Kreppner S; Fietkau R
Strahlenther Onkol; 2015 Jun; 191(6):495-500. PubMed ID: 25575981
[TBL] [Abstract][Full Text] [Related]
31. Survival analysis of HDR brachytherapy versus reoperation versus temozolomide alone: a retrospective cohort analysis of recurrent glioblastoma multiforme.
Archavlis E; Tselis N; Birn G; Ulrich P; Baltas D; Zamboglou N
BMJ Open; 2013 Mar; 3(3):. PubMed ID: 23503605
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme.
Maier-Hauff K; Ulrich F; Nestler D; Niehoff H; Wust P; Thiesen B; Orawa H; Budach V; Jordan A
J Neurooncol; 2011 Jun; 103(2):317-24. PubMed ID: 20845061
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of gamma knife radiosurgery for small-volume recurrent malignant gliomas after initial radical resection.
Elliott RE; Parker EC; Rush SC; Kalhorn SP; Moshel YA; Narayana A; Donahue B; Golfinos JG
World Neurosurg; 2011; 76(1-2):128-40; discussion 61-2. PubMed ID: 21839964
[TBL] [Abstract][Full Text] [Related]
34. Impact of multimodal therapy in locally recurrent rectal cancer.
You YN; Skibber JM; Hu CY; Crane CH; Das P; Kopetz ES; Eng C; Feig BW; Rodriguez-Bigas MA; Chang GJ
Br J Surg; 2016 May; 103(6):753-762. PubMed ID: 26933792
[TBL] [Abstract][Full Text] [Related]
35. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
36. Multiple resections and survival of recurrent glioblastoma patients in the temozolomide era.
Ortega A; Sarmiento JM; Ly D; Nuño M; Mukherjee D; Black KL; Patil CG
J Clin Neurosci; 2016 Feb; 24():105-11. PubMed ID: 26671314
[TBL] [Abstract][Full Text] [Related]
37. Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the Central Nervous System Study Group of Airo (italian Association of Radiation Oncology).
Scoccianti S; Magrini SM; Ricardi U; Detti B; Buglione M; Sotti G; Krengli M; Maluta S; Parisi S; Bertoni F; Mantovani C; Tombolini V; De Renzis C; Lioce M; Fatigante L; Fusco V; Muto P; Berti F; Rubino G; Cipressi S; Fariselli L; Lupattelli M; Santoni R; Pirtoli L; Biti G
Neurosurgery; 2010 Aug; 67(2):446-58. PubMed ID: 20644432
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma.
Filippini G; Falcone C; Boiardi A; Broggi G; Bruzzone MG; Caldiroli D; Farina R; Farinotti M; Fariselli L; Finocchiaro G; Giombini S; Pollo B; Savoiardo M; Solero CL; Valsecchi MG;
Neuro Oncol; 2008 Feb; 10(1):79-87. PubMed ID: 17993634
[TBL] [Abstract][Full Text] [Related]
39. Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery.
Stummer W; Meinel T; Ewelt C; Martus P; Jakobs O; Felsberg J; Reifenberger G
J Neurooncol; 2012 May; 108(1):89-97. PubMed ID: 22307805
[TBL] [Abstract][Full Text] [Related]
40. Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: A comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling time.
Kollmeier MA; McBride S; Taggar A; Anderson E; Lin M; Pei X; Weiji S; Voros L; Cohen G; Yamada Y; Zelefsky MJ
Brachytherapy; 2017; 16(6):1091-1098. PubMed ID: 28838648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
